Biogen bgen announced that the U.S. Food and Drug Administration has approved a label change for its multiple sclerosis drug Avonex, lowering the rate of occurrence of neutralizing antibodies to 5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback